ACE2 and COVID-19: Furthermore, treating hypertension with ACE inhibitors or angiotensin receptor blockers (ARBs) can increase ACE2 levels, making COVID-19 patients more vulnerable to SARS-CoV-2 infection and decreasing their prognosis.